Royalty Pharma - New Capital Deployment Target Of $10-12 Billion Over The Next Five Years

Reuters
2022.05.17 11:47
portai
I'm PortAI, I can summarize articles.

路透 5 月 17 日電-Royalty Pharma PLC：

路透 5 月 17 日電-Royalty Pharma PLC(RPRX.O)：

  • Royalty Pharma-未來五年新資本部署目標為 100-120 億美元

  • 特許權使用費製藥-2020-2025 年調整後現金收入 (非 GAAP) 複合年增長率提高至 11-14%

  • Royalty Pharma-看到學術機構，非營利組織將在未來十年花費超過 1 萬億美元資助生命科學的研究和開發

  • Royalty Pharma-推出其目標，從 2020 年到 2030 年，調整後的現金收入每年複合增長 10% 或更多，進一步擴大公司覆蓋範圍：(RPRX.O)

Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.